Tessera gets up to $50M from the Gates Foundation; Tvardi’s reverse merger

Plus, news about Sensorion, Soleno Therapeutics, Corvus and Hansa Biopharma:

Tessera Therapeutics bags up to $50M for sickle cell disease R&D: The investment is part …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Pharma has over $500B in capital for deals

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Today we

May 8, 2024

FDA Approves TriClip; Fortified Eggs vs Cholesterol; Impella Maker Chided

Abbott said its TriClip transcatheter edge-to-edge repair system snagged FDA approval for treating for tricuspid regurgitation. Medtronic announced that the FDA approved the Evolut FX+

April 3, 2024

New AI imaging technique enhances retinal disorder diagnosis

Population-based studies have shown retinal disorders are the most common cause of irreversible blindness in developed countries and the second most common cause of blindness

September 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.